238 related articles for article (PubMed ID: 7961017)
1. Esophageal cancer treated with radiotherapy: impact of total treatment time and fractionation.
Nishimura Y; Ono K; Tsutsui K; Oya N; Okajima K; Hiraoka M; Abe M
Int J Radiat Oncol Biol Phys; 1994 Dec; 30(5):1099-105. PubMed ID: 7961017
[TBL] [Abstract][Full Text] [Related]
2. Multi-institutional randomized trial of external radiotherapy with and without intraluminal brachytherapy for esophageal cancer in Japan. Japanese Society of Therapeutic Radiology and Oncology (JASTRO) Study Group.
Okawa T; Dokiya T; Nishio M; Hishikawa Y; Morita K
Int J Radiat Oncol Biol Phys; 1999 Oct; 45(3):623-8. PubMed ID: 10524414
[TBL] [Abstract][Full Text] [Related]
3. High-dose-rate brachytherapy boost following concurrent chemoradiotherapy for esophageal carcinoma.
Yorozu A; Dokiya T; Oki Y
Int J Radiat Oncol Biol Phys; 1999 Sep; 45(2):271-5. PubMed ID: 10487545
[TBL] [Abstract][Full Text] [Related]
4. Influence of intraluminal brachytherapy dose on complications in the treatment of esophageal cancer.
Kumar MU; Swamy K; Supe SS; Anantha N
Int J Radiat Oncol Biol Phys; 1993 Dec; 27(5):1069-72. PubMed ID: 8262829
[TBL] [Abstract][Full Text] [Related]
5. [Choice of fractionation regimen in radiotherapy of inoperable esophageal cancer].
Val'kov MIu; Zolotkov AG; Mardynskiĭ IuS; Asakhin SM
Vopr Onkol; 2003; 49(5):651-6. PubMed ID: 14682142
[TBL] [Abstract][Full Text] [Related]
6. Results of external irradiation and low-dose-rate intraluminal brachytherapy for esophageal cancer.
Someya M; Sakata K; Saito A; Nagakura H; Oouchi A; Hareyama M
Acta Oncol; 2002; 41(1):63-8. PubMed ID: 11990521
[TBL] [Abstract][Full Text] [Related]
7. The safety and usefulness of neutron brachytherapy and external beam radiation in the treatment of patients with gastroesophageal junction adenocarcinoma with or without chemotherapy.
Wang Q; Li T; Liu H; Jia X; Liu B; Wan X; Lang J
Radiat Oncol; 2014 Apr; 9():99. PubMed ID: 24774780
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcomes and prognostic factors for patients with early esophageal squamous cell carcinoma treated with definitive radiation therapy alone.
Ishikawa H; Sakurai H; Yamakawa M; Saito Y; Nakayama Y; Kitamoto Y; Okamoto M; Harada K; Hasegawa M; Nakano T
J Clin Gastroenterol; 2005 Jul; 39(6):495-500. PubMed ID: 15942435
[TBL] [Abstract][Full Text] [Related]
9. Accelerated hyperfractionation (AHF) compared to conventional fractionation (CF) in the postoperative radiotherapy of locally advanced head and neck cancer: influence of proliferation.
Awwad HK; Lotayef M; Shouman T; Begg AC; Wilson G; Bentzen SM; Abd El-Moneim H; Eissa S
Br J Cancer; 2002 Feb; 86(4):517-23. PubMed ID: 11870530
[TBL] [Abstract][Full Text] [Related]
10. High dose rate brachytherapy for superficial cancer of the esophagus.
Maingon P; d'Hombres A; Truc G; Barillot I; Michiels C; Bedenne L; Horiot JC
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):71-6. PubMed ID: 10656375
[TBL] [Abstract][Full Text] [Related]
11. External beam radiation therapy with or without high-dose-rate intraluminal brachytherapy for patients with superficial esophageal carcinoma.
Nishimura Y; Okuno Y; Ono K; Mitsumori M; Nagata Y; Hiraoka M
Cancer; 1999 Jul; 86(2):220-8. PubMed ID: 10421257
[TBL] [Abstract][Full Text] [Related]
12. Accelerated fractionation in esophageal cancers: a multivariate analysis on 88 patients.
Girinsky T; Auperin A; Marsiglia H; Dhermain F; Randrianarivelo H; Kac J; Ducreux M; Elias D; Rougier P
Int J Radiat Oncol Biol Phys; 1997 Jul; 38(5):1013-8. PubMed ID: 9276367
[TBL] [Abstract][Full Text] [Related]
13. External beam radiation therapy followed by high-dose-rate brachytherapy for inoperable superficial esophageal carcinoma.
Pasquier D; Mirabel X; Adenis A; Rezvoy N; Hecquet G; Fournier C; Coche-Dequeant B; Prevost B; Castelain B; Lartigau E
Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1456-61. PubMed ID: 16863928
[TBL] [Abstract][Full Text] [Related]
14. Improved results with accelerated hyperfractionated radiotherapy of advanced head and neck cancer.
Leborgne F; Zubizarreta E; Fowler J; Ortega B; Mezzera J; Deus JL; Leborgne JH
Int J Cancer; 2000 Apr; 90(2):80-91. PubMed ID: 10814958
[TBL] [Abstract][Full Text] [Related]
15. Radiotherapy with high dose rate brachytherapy boost and concomitant chemotherapy for Stages IIB and III esophageal carcinoma: results of a pilot study.
Calais G; Dorval E; Louisot P; Bourlier P; Klein V; Chapet S; Reynaud-Bougnoux A; Huten N; De Calan L; Aget H; Le Floch O
Int J Radiat Oncol Biol Phys; 1997 Jul; 38(4):769-75. PubMed ID: 9240645
[TBL] [Abstract][Full Text] [Related]
16. Comparison of efficacy and safety of low-dose-rate vs. high-dose-rate intraluminal brachytherapy boost in patients with superficial esophageal cancer.
Tamaki T; Ishikawa H; Takahashi T; Tamaki Y; Kitamoto Y; Okamoto M; Noda SE; Katoh H; Shirai K; Sakurai H; Nakano T
Brachytherapy; 2012; 11(2):130-6. PubMed ID: 21700506
[TBL] [Abstract][Full Text] [Related]
17. Esophageal cancer. A prospective phase II study of concomitant-boost external-beam chemoradiation with a top-up endoluminal boost.
Brunner TB; Rupp A; Melzner W; Grabenbauer GG; Sauer R
Strahlenther Onkol; 2008 Jan; 184(1):15-22. PubMed ID: 18188518
[TBL] [Abstract][Full Text] [Related]
18. Comparison between continuous accelerated hyperfractionated and late-course accelerated hyperfractionated radiotherapy for esophageal carcinoma.
Wang Y; Shi XH; He SQ; Yao WQ; Wang Y; Guo XM; Wu GD; Zhu LX; Liu TF
Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):131-6. PubMed ID: 12182982
[TBL] [Abstract][Full Text] [Related]
19. Optimum fractionation for high-dose-rate endoesophageal brachytherapy following external irradiation of early stage esophageal cancer.
Akagi Y; Hirokawa Y; Kagemoto M; Matsuura K; Ito A; Fujita K; Kenjo M; Kiriu H; Ito K
Int J Radiat Oncol Biol Phys; 1999 Feb; 43(3):525-30. PubMed ID: 10078632
[TBL] [Abstract][Full Text] [Related]
20. Hyperfractionated radiation in the treatment of squamous cell carcinomas of the head and neck: a comparison of two fractionation schedules.
Garden AS; Morrison WH; Ang KK; Peters LJ
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):493-502. PubMed ID: 7852111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
